Literature DB >> 25910625

Development of a recombinant OppA-based indirect hemagglutination test for the detection of antibodies against Haemophilus parasuis.

Shengli Chen1, Yuefeng Chu1, Ping Zhao1, Ying He1, Yingna Jian1, Yongsheng Liu1, Zhongxin Lu2.   

Abstract

An indirect hemagglutination (IHA) test that could detect antibodies against Haemophilus parasuis was developed. The full-length cDNA sequence of the oligopeptide permease ABC transporter membrane protein (OppA) gene was cloned, and inserted into the prokaryotic expression vector pET-30a(+) to construct recombinant plasmid pET-30a-OppA. The recombinant OppA protein was expressed partly in soluble form in Escherichia coli BL21 (DE3) and then purified by Ni(2+) column. Furthermore, the recombinant OppA protein was used as an antigen to develop an IHA assay for detecting antibodies against H. parasuis. Results showed that this IHA test could detect species-specific antibodies against H. parasuis. Compared with currently available ELISA, the IHA test had a sensitivity of 85.0% and a specificity of 95.0%. The overall agreement between these two methods was 90.0%. The developed IHA test was used to evaluate the seroprevalence of H. parasuis in Hubei Province, China. The H. parasuis seroprevalence rate ranged from 5.5% to 26.2% in 325 tested clinical serum samples that were collected from three different pig farms in Hubei Province, China. The IHA test developed in this study will greatly contribute to the epidemiological surveys and immunization surveillance of H. parasuis.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody detection; Haemophilus parasuis; Indirect hemagglutination test; OppA

Mesh:

Substances:

Year:  2015        PMID: 25910625     DOI: 10.1016/j.actatropica.2015.04.009

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  6 in total

1.  Analysis of efficacy obtained with a trivalent inactivated Haemophilus parasuis serovars 4, 5, and 12 vaccine and commercial vaccines against Glässer's disease in piglets.

Authors:  Zhanqin Zhao; Huisheng Liu; Yun Xue; Kunpeng Chen; Zhijun Liu; Qiao Xue; Chen Wang
Journal:  Can J Vet Res       Date:  2017-01       Impact factor: 1.310

2.  Minimum dose, antigen content, and immunization duration of a trivalent vaccine of inactivated Haemophilus parasuis serovars 4, 5, and 12 against Glässer's disease in pigs.

Authors:  Zhanqin Zhao; Huisheng Liu; Keshan Zhang; Qiao Xue; Kunpeng Chen; Yun Xue
Journal:  Can J Vet Res       Date:  2016-10       Impact factor: 1.310

3.  Evaluation of immunogenicity and protective efficacy of recombinant outer membrane proteins of Haemophilus parasuis serovar 5 in a murine model.

Authors:  Miao Li; Ru-Jian Cai; Shuai Song; Zhi-Yong Jiang; Yan Li; Hong-Chao Gou; Pin-Pin Chu; Chun-Ling Li; Hua-Ji Qiu
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

4.  Prevalence and seroepidemiology of Haemophilus parasuis in Sichuan province, China.

Authors:  Zhenghao Wang; Qin Zhao; Hailin Wei; Xintian Wen; Sanjie Cao; Xiaobo Huang; Rui Wu; Qigui Yan; Yong Huang; Yiping Wen
Journal:  PeerJ       Date:  2017-05-30       Impact factor: 2.984

5.  Epidemiology of Haemophilus parasuis isolates from pigs in China using serotyping, antimicrobial susceptibility, biofilm formation and ERIC-PCR genotyping.

Authors:  Yongda Zhao; Qin Wang; Jie Li; Xiaohuan Lin; Xianhui Huang; Binghu Fang
Journal:  PeerJ       Date:  2018-06-13       Impact factor: 2.984

6.  Development and application of an antibody detection ELISA for Haemophilus parasuis based on a monomeric autotransporter passenger domain.

Authors:  Yunbao Liu; Yujiao Du; Yuping Song; Yang Tian; Yi Qi; Qinxue Zhang; Qigai He; Xiangru Wang; Huanchun Chen; Xuwang Cai; Xiaojuan Xu
Journal:  BMC Vet Res       Date:  2019-12-03       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.